588 related articles for article (PubMed ID: 27353055)
1. FibroScan, APRI, FIB4, and GUCI: Role in prediction of fibrosis and response to therapy in Egyptian patients with HCV infection.
Yosry A; Fouad R; Alem SA; Elsharkawy A; El-Sayed M; Asem N; Hassan E; Ismail A; Esmat G
Arab J Gastroenterol; 2016 Jun; 17(2):78-83. PubMed ID: 27353055
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive fibrosis assessment predicts sustained virological response to telaprevir with pegylated interferon and ribavirin for chronic hepatitis C.
Ogawa E; Furusyo N; Shimizu M; Ihara T; Hayashi T; Harada Y; Toyoda K; Murata M; Hayashi J
Antivir Ther; 2015; 20(2):185-92. PubMed ID: 24941012
[TBL] [Abstract][Full Text] [Related]
3. Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment.
El Raziky M; Attia D; El Akel W; Shaker O; Khatab H; Abdo S; Elsharkawy A; Esmat G
Arab J Gastroenterol; 2013 Sep; 14(3):94-8. PubMed ID: 24206736
[TBL] [Abstract][Full Text] [Related]
4. The PAPAS index: a novel index for the prediction of hepatitis C-related fibrosis.
Ozel BD; Poyrazoğlu OK; Karaman A; Karaman H; Altinkaya E; Sevinç E; Zararsiz G
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):895-900. PubMed ID: 25951491
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.
Fouad SA; Esmat S; Omran D; Rashid L; Kobaisi MH
World J Gastroenterol; 2012 Jun; 18(23):2988-94. PubMed ID: 22736923
[TBL] [Abstract][Full Text] [Related]
6. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
[TBL] [Abstract][Full Text] [Related]
7. Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C: a prospective study.
Papastergiou V; Stampori M; Lisgos P; Pselas C; Prodromidou K; Karatapanis S
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):798-805. PubMed ID: 23395996
[TBL] [Abstract][Full Text] [Related]
8. Elastography and serum markers of fibrosis versus liver biopsy in 1270 Egyptian patients with hepatitis C.
Abdelsameea E; Alsebaey A; Abdel-Razek W; Ehsan N; Morad W; Salama M; Waked I
Eur J Gastroenterol Hepatol; 2020 Dec; 32(12):1553-1558. PubMed ID: 31972660
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C genotype 4 with normal transaminases: correlation with fibrosis and response to treatment, a cohort Egyptian study of 4277 patients.
Abdel-Rahman M; Saad Y; El-Raziky M; Zayed N; El-Akel W; Said M; El-Beshlawy M; Esmat G
Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):479-84. PubMed ID: 23540379
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C infection at a tertiary hospital in South Africa: Clinical presentation, non-invasive assessment of liver fibrosis, and response to therapy.
Abuelhassan WB; Gasim GI; Ally R; Menezes C
S Afr Med J; 2020 Aug; 110(9):920-925. PubMed ID: 32880279
[TBL] [Abstract][Full Text] [Related]
11. Fibro-indices versus liver stiffness for prediction of significant fibrosis in hepatitis B virus-infected Egyptian patients; a single-center experience.
Said M; Eletreby R; Omar H; Dabees H; Abdelghafour R; El-Serafy M; Doss W
Expert Rev Gastroenterol Hepatol; 2020 Mar; 14(3):221-227. PubMed ID: 32031424
[No Abstract] [Full Text] [Related]
12. Hepatitis C Viral Kinetic Changes in a Retrospective Cohort Study of Chronic Hepatitis C Virus Egyptian Patients on Pegylated Interferon and Ribavirin Therapy.
Esmat GE; Al Akel W; Abdel Aziz RA; Al Sayed Taha A; Sabry D; Rashed LA; Mostafa A; El Kazaz AY; Ahmed SH
J Interferon Cytokine Res; 2016 Mar; 36(3):149-58. PubMed ID: 26982165
[TBL] [Abstract][Full Text] [Related]
13. Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy.
Liang CC; Liu CH; Chung CS; Lin CK; Su TH; Yang HC; Liu CJ; Chen PJ; Chen DS; Kao JH
J Infect Dis; 2015 May; 211(9):1429-36. PubMed ID: 25387585
[TBL] [Abstract][Full Text] [Related]
14. The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C.
Gökcan H; Kuzu UB; Öztaş E; Saygılı F; Öztuna D; Suna N; Tenlik İ; Akdoğan M; Kaçar S; Kılıç ZM; Kayaçetin E
Turk J Gastroenterol; 2016 Mar; 27(2):156-64. PubMed ID: 26853790
[TBL] [Abstract][Full Text] [Related]
15. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
Lackner C; Struber G; Liegl B; Leibl S; Ofner P; Bankuti C; Bauer B; Stauber RE
Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
[TBL] [Abstract][Full Text] [Related]
16. Utility and limitations of APRI and FIB4 to predict staging in a cohort of nonselected outpatients with hepatitis C.
de Oliveira AC; El-Bacha I; Vianna MV; Parise ER
Ann Hepatol; 2016; 15(3):326-32. PubMed ID: 27049486
[TBL] [Abstract][Full Text] [Related]
17. Adipokines and insulin resistance, predictors of response to therapy in Egyptian patients with chronic hepatitis C virus genotype 4.
Saad Y; Ahmed A; Saleh DA; Doss W
Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):920-5. PubMed ID: 23442415
[TBL] [Abstract][Full Text] [Related]
18. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients.
Omran D; Zayed RA; Nabeel MM; Mobarak L; Zakaria Z; Farid A; Hassany M; Saif S; Mostafa M; Saad OK; Yosry A
Viral Immunol; 2018 May; 31(4):315-320. PubMed ID: 29630460
[TBL] [Abstract][Full Text] [Related]
19. Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin.
Ng KJ; Tseng CW; Chang TT; Tzeng SJ; Hsieh YH; Hung TH; Huang HT; Wu SF; Tseng KC
Clin Interv Aging; 2016; 11():1035-41. PubMed ID: 27536084
[TBL] [Abstract][Full Text] [Related]
20. The assessment of data mining for the prediction of therapeutic outcome in 3719 Egyptian patients with chronic hepatitis C.
Zayed N; Awad AB; El-Akel W; Doss W; Awad T; Radwan A; Mabrouk M
Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):254-61. PubMed ID: 23141214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]